U.S. pharma giant Bristol-Myers Squibb has struck a partnership and licensing deal with Chinese drugmaker Hengrui, in a deal that could worth more than $15 billion. Sam Altman's Business Dealings ...

Roche CEO Expects Pharma Portfolio to Deliver Sales Growth Through 2030 The drugmaker's on-market pharma portfolio, together with drugs for lupus, breast cancer and multiple sclerosis, should offset ...

Scientists in Germany have pulled off a staggering computing feat by fully simulating a 50-qubit quantum computer for the ...

Before this week’s U.S.-Chinese summit, Beijing reached a milestone in its quest for technological self-sufficiency.